JB Chemicals & Pharmaceuticals has informed that this has reference to disclosures earlier made in relation to Order dated 8-1-2016 passed by National Green Tribunal (‘NGT’) which directed the closure of industrial activities at the Company’s built drugs plant at Panoli, Gujarat. They also refer to disclosure made on May 19, 2016 informing the Exchange that NGT by Judgement and Order dated 17-5-2016 did not allow the Company’s Application for review of the Order passed on 8-1-2016 (Collectively the ‘Orders’). They now wish to inform the Exchange that on an appeal filed by the Company challenging the aforementioned Orders of NGT, the Supreme Court has stayed the operation of the Orders passed by NGT. The Company believes that it has all necessary clearances and consents to carry on its industrial activities at the said plant and is in compliance with the applicable laws.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: